January 9, 2024 · Form 4 insider transaction
Mirviss Jeffrey B. sold 15,172 shares of Boston Scientific Corporation at $59.25 per share, a transaction worth $898.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 25, 2023.